Literature DB >> 24633445

Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome.

Shuichiro Fujinaga1, Taichi Hara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24633445     DOI： 10.1007/s00467-014-2800-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome.

Authors:  Daishi Hirano; Shuichiro Fujinaga; Naoto Nishizaki
Journal:  Clin Nephrol       Date:  2012-06       Impact factor: 0.975

2.  Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin.

Authors:  Hiroshi Kaito; Koichi Kamei; Eriko Kikuchi; Masao Ogura; Kentaro Matsuoka; Michio Nagata; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2009-12-22       Impact factor: 3.714

3.  Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome.

Authors:  Koichi Kamei; Mari Okada; Mai Sato; Takuya Fujimaru; Masao Ogura; Makiko Nakayama; Hiroshi Kaito; Kazumoto Iijima; Shuichi Ito
Journal:  Pediatr Nephrol       Date:  2014-02-06       Impact factor: 3.651
  3 in total
  1 in total

Review 1.  Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.

Authors:  Koichi Kamei; Kenji Ishikura; Mayumi Sako; Shuichi Ito; Kandai Nozu; Kazumoto Iijima
Journal:  Pediatr Nephrol       Date:  2018-12-18       Impact factor: 3.714
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.